Metabolic syndrome and its components predict the biochemical recurrence and adverse pathological features of patients following radical prostatectomy: A propensity score matching study

To investigate the predictive value of metabolic syndrome (MetS) and its components in biochemical recurrence (BCR) and adverse pathological features of patients with prostate cancer (PCa) after radical prostatectomy (RP).